Background: It has been generally accepted that deep brain stimulation (DBS) not only acts in the nucleus where it is being applied, as initially thought, but that chronic stimulation activates axons located in its scope, and that this activation can exert its effects in distant areas. Considering this, DBS target identification should be made based on techniques that identify white matter tracts, such as tractography, rather than only by identifying specific nuclei on conventional magnetic resonance imaging. Methods: In this study, we performed a review of the literature on the use of tractography in DBS surgery and provide an overview of the main results. Results: Tractography has been used in the field of DBS to help clarify relevant aspects in the selection of targets and in evaluating its therapeutic effects in movement disorders, psychiatric diseases and pain. Conclusions: Studies are scarce so far, but they have provided data that, if confirmed, may optimize DBS surgery. Tractography might become a routine tool for DBS surgery in the near future.

Chronic deep brain stimulation (DBS) has become a widely used surgical treatment for an increasing number of medication-resistant neurological and psychiatric disorders [1]. There are studies that have shown that DBS not only inhibits the neuronal activity in the nucleus where it is being applied, as initially thought, but that chronic stimulation produces an activation of axons located in its scope, and that this activation can exert its effects in distant areas [2]. Although the net effect of the DBS would be a sum of its effects on local and remote structures, which is difficult to determine [2], it has been suggested that such fiber tract activation might override the transmission of pathological bursting and oscillatory activity through the stimulated nuclei [1].

Considering this, DBS target identification should be made using techniques that identify white matter tracts, rather than only by identifying specific nuclei on conventional magnetic resonance imaging (MRI) [3], hence the transcendence that integrating diffusion tensor imaging (DTI)-based tractography might entail.

Tractography provides 3D graphic reconstructions of the cerebral white matter fibers via DTI. DTI is a technique that is based on MRI, capable of determining the trend of the diffusion of water particles in the different directions and, therefore, the main direction of a bundle of white matter fibers contained in a voxel. It is a noninvasive technique that is gaining popularity because it allows the delineation of white matter tracts in vivo and evaluation of the connectivity of different brain areas [4]. There are methods that, incorporated within the tractography technique, can predict the volume of tissue activated by DBS on brain tracts. This could help develop accurate predictions of the effects of DBS in brain regions distant from the target and foresee the possible adverse effects produced by the stimulation as it increases [5].

The number of published studies in which tractography has been used for selecting DBS targets, or for the study of the pathways involved in their therapeutic action, is scarce (table 1). The aim of this paper is to review the literature on the use of tractography in DBS surgery and to provide an overview of the main results.

Table 1

Published studies on tractography and DBS surgery

Published studies on tractography and DBS surgery
Published studies on tractography and DBS surgery

Tractography is a relatively new technique, and experience with it around the world is relatively scarce. It is currently questioned for its possibly low correlation with anatomical structures and poor reproducibility [2]. Sedrak et al. [6], in 2008, used tractography to determine the connectivity of several DBS targets for neurological and psychiatric disorders with other brain areas and to analyze the correspondence of these results with known data through other techniques. The studied areas were the cingulate gyrus, Brodmann area 25, amygdala, posterior hypothalamus, orbitofrontal cortex, nucleus accumbens, anterior limb of the internal capsule and dorsomedial thalamus in 15 patients undergoing stereotactic surgery for movement disorders. The authors obtained connectivity patterns consistent with those of other tractography studies and with previously known data, and therefore concluded that tractography is reliable for identifying connectivity patterns in the brain and for planning DBS targets. In another study comparing tractography with neurophysiological monitoring using microelectrodes, an overlap in certain areas such as the thalamus was obtained, whereas it showed poorer correspondence with the neurophysiological results in other areas [7].

It seems increasingly likely that tractography might yield reliable and reproducible results if it is performed under certain conditions [8,9]. In a study in which the probabilistic method was used to analyze the reproducibility of tractography from a qualitative perspective, the results were satisfactory in 6 out of 8 subjects if tractography was used for segmenting the thalamus. However, for the other 2 cases, the authors obtained a poor segmentation, which was probably related to the lower quality of the obtained data [8]. In another study by Traynor et al. [9] in 2010, the authors analyzed the reproducibility of thalamic segmentation from a quantitative point of view in a single subject. Multiple analyses were performed using the same database obtained from the subject, varying the probabilistic tractography algorithm conditions. Subsequently, the authors conducted an analysis of other data sets that were acquired independently from the same subject. Thalamic segmentation also proved to be very reproducible using 6 target cortical regions, although the reproducibility was reduced when the number of target regions increased, especially in the medial and posterior thalamus. When the analysis was extended to a group of normal subjects, the results showed a high degree of overlap, particularly in thalamic regions with connections to the frontal, parietal, temporal and precentral cortex.

Movement Disorders

Since the 1980s, when the first patient was treated with DBS for essential tremor, DBS has been established as a standard therapy for movement disorders that cannot be controlled with medication [10,11,12,13]. Currently, there are over 100,000 patients worldwide treated with DBS for movement disorders [11,12,13,14]. Although DBS controls the main symptoms, some manifestations of these disorders do not improve with stimulation in the usual targets [15]. Furthermore, there is still no certainty about the pathways involved in the mechanism of action of DBS, and which are responsible for many of its side effects [16]. Tractography has begun to be used to investigate these issues, with some results [17].

In a paper published by Barkhoudarian et al. [17] in 2010, the authors studied 3 patients undergoing stereotactic surgery for movement disorders by tractography [one patient had Parkinson's disease (PD), another had essential tremor and the third one had dystonia related to cerebral palsy] to establish the pathways involved in the therapeutic effect and side effects of the stimulation. The stereotactic targets were the subthalamic nucleus (STN), ventral intermediate nucleus (Vim) and globus pallidus, respectively. The authors selected the contacts with an obvious clinical effect in every patient. In patient 1, the fibers that left the active contact (in the STN) ended in the precentral and premotor cortex, in particular in the area responsible for hand movements. However, increasing the size of the volume of interest (VOI), which simulates an increase in the stimulation voltage, incorporated additional fiber tracts connected laterally to the prefrontal and parietal cortex as well as to the occipitofrontalis bundle. In addition, there appeared to be some tracts approaching the region of the frontal visual fields (Brodmann area 8). In patient 2, undergoing DBS of the Vim, tracts were observed in the premotor and motor cortex when the small VOI was used. By increasing the VOI, additional extensions to the prefrontal, supplementary and motor cortex as well as the parietal lobes and cerebellum were obtained. In patient 3, with DBS in the globus pallidus, there were connections to the motor, prefrontal and parietal sensory cortex and to the eye fields and cerebellum when the VOI was increased. The authors observed an association between certain motor side effects and activation by the stimulation of fibers directed to the premotor and supplementary cortex in this patient. However, it was not possible to establish specific relationships between the cortical regions affected by increasing the size of VOIs and the occurrence of side effects in other patients [18].

Parkinson's Disease

It is generally accepted that one of the optimal locations for DBS electrode implantation for PD is the posterolateral area of the STN. However, axial symptoms and gait disturbances are generally not adequately controlled with stimulation in the STN [15]. Recently, the region of the pedunculopontine nucleus (PPN) has gained importance as a potential target for patients with PD and gait disorders and falls as the predominant symptoms [19]. In principle, it is thought that the presence of PPN connections to the globus pallidus can help counteract the inhibitory influence on it observed in PD [20].

The PPN has been studied using tractography to identify its main connections [20,21]. In a study by Aravamuthan et al. [20], the authors studied the brain regions with greater connectivity to the PPN in 8 patients, placing a VOI in the PPN in each hemisphere and considering only those that were present in 4 of the 8 subjects. PPN connections existed to the cortex, basal ganglia, cerebellum and spinal cord, with a similar distribution to those demonstrated in primates. In a longitudinal study published by Schweder et al. [21] in 2010, the authors examined the long-term effect of low-frequency bilateral stimulation in the connectivity of the PPN region in a patient with PD and frozen gait. Probabilistic tractography and a topographic map were used to locate the region of the PPN through the identification of the medial lemniscus and the superior cerebellar decussation. The preoperative connectivity in the patient was altered compared to healthy controls, showing a lack of connectivity with the cerebellum and an increased connectivity with the pons above the level of the middle section of the fourth ventricle. The connectivity was excessive relative to that of the healthy controls in the motor cortex, particularly in the area of the cortical homunculus representing the lower extremities. Upon stimulation, the connectivity to the cerebellum increased and that to the brainstem significantly decreased; thus, it normalized compared to healthy subjects [22].

Tremor

Tractography has contributed to the implementation of DBS surgery for tremor in two fundamental ways. First, it has served to more precisely characterize the circuits involved in the genesis and treatment of tremor and to identify the most effective thalamic regions for DBS application based on their connectivity. Secondly, the dentatorubrothalamic tract (DRT) has been identified as a possible target for the application of DBS, as an alternative to the Vim or ventral oral thalamic nucleus [18].

The Vim of the thalamus is the typical target structure, among other nuclei in the ventral thalamus, typically used for the treatment with DBS for refractory tremor [23]. Several studies have been conducted to characterize the neural network involved in the pathogenesis and treatment of tremor, based on the analysis of the connectivity from these thalamic areas [8,24,25]. In a study conducted by Klein et al. [24], the authors studied 12 patients undergoing DBS of the Vim for disabling tremor by tractography. The tractography was initiated at the effective contacts and produced a highly reproducible network of connectivity to motor regions comprising cortical and subcortical structures, the cerebellum and the brainstem. In this group, the most effective contacts were found in the thalamic area that was more connected to the primary motor cortex. However, in a paper published by Pouratian et al. [25] in 2011, although the authors started from the same hypothesis, the results suggested that the primary target for tremor should be the thalamic region, with the highest probability of connectivity to the premotor and supplementary cortex. For that, the authors studied 6 patients who had been operated on for the treatment of tremor in the upper extremities. All electrodes were implanted by traditional methods (based on the selected coordinates and intraoperative findings of stimulation) and programmed for optimum efficiency. The results showed that the most effective contacts were those situated in tracts ending in the supplementary and premotor cortex [8,25].

Some studies indicate that the posterior area of the STN as well as the caudal region of the zona incerta can be equally or even more effective targets for the treatment of certain forms of tremor, associated with a lower probability of dysarthria and other incapacitating side effects compared to DBS of the Vim [16,23,26]. In fact, some authors concluded that the efficacy of the lesion and Vim DBS could be mediated by stimulation of the DRT, consisting of the projections from the cerebellum to the contralateral thalamus [27].

There are several studies where tractography was used to confirm this hypothesis and to identify the DRT as a target for the implantation of DBS for the treatment of tremor. Coenen et al. [18], in 2011, implemented this methodology in 2 cases: a patient with PD and another patient with dystonic cephalic tremor. The authors used probabilistic tractography and identified the area of the pyramidal pathway. Then they tried to find the DRT by applying a VOI in the brainstem, including the midline and the cerebral peduncles. The resulting fibers were selected following the superior cerebellar peduncle, and another VOI was applied incorporating the ipsilateral dentate nucleus. As a final step, a third VOI was placed around the fibers that reached the precentral gyrus. The DRT was identified in the vicinity of the pyramidal tract and medial lemniscus. Merging data from postoperative CT revealed the exact location of the DBS electrode with respect to the adjacent fiber tracts. The evaluation of the electric fields surrounding the electrodes allowed the identification of the DRT as the target of stimulation [18,28].

Psychiatric Disorders

DBS is being used for the treatment of an increasing number of psychiatric disorders [29,30,31,32,33]. It has confirmed its effectiveness in a significant percentage of patients with obsessive-compulsive disorder (OCD), major depression and Tourette's syndrome, and it is being investigated as a treatment for obesity and addiction [34,35,36,37,38,39,40,41].

In recent years, different targets have been proposed for the surgical treatment of depression and OCD. These targets have emerged mostly because they showed abnormalities on positron emission tomography (PET) in chronic patients that disappeared when the patients responded to different treatments [29,32,42,43]. The main targets used for depression and OCD are the subgenual cingulate, the anterior limb of the internal capsule and the nucleus accumbens, which have a very similar efficiency (50-60%) and need the application of high voltages of stimulation to produce clinical benefits [28]. The multiplicity of targets and their comparable efficacy raises questions about what the anatomical structures explicitly responsible for the therapeutic benefits of DBS are [44].

According to Coenen's group, the fundamental structure responsible for the therapeutic action of these targets could be the medial forebrain bundle (MFB), which is part of the motivation and reward system. This group performed a theoretical study in 2012, in which they theoretically represented (using a probabilistic tractography map) the white matter tracts affected by the stimulation of the three abovementioned targets and their relationship to the MFB [18,28]. They showed that the MFB is partially included in the electric field at different target sites of depression by 92% [18,28].

DTI has also been used to identify axonal pathways activated by stimulation and its correlation with the individual clinical outcome [42,43]. In a study conducted by Lujan et al. [30] in 2012, 7 patients with depression treated with DBS of the ventral anterior internal capsule and ventral striatum were studied. The treatment responders showed 5 pathways medial and lateral to the ventral striatum, or dorsal and lateral to the nucleus accumbens, which were similarly activated by DBS. There was also a common pathway activated in those who had not responded to treatment. In another study by Johansen-Berg et al. [42] in 2008 to identify anatomical pathways underlying the therapeutic response, the authors studied the connections between the region of the anterior cingulate cortex (ACC) and the areas that change their metabolism in response to stimulation for depression. They also analyzed the connectivity of the areas surrounding the active contacts in 9 responders in order to define the anatomic pathways likely affected by the stimulation. The authors found that although most of the connections were common to the whole ACC area, the probability of a connection differed depending on the location within that area. Connections to the amygdala, hypothalamus, nucleus accumbens and orbitofrontal cortex were more likely in the posterior subgenual region. Connections to the medial and frontopolar ACC were more prominent in the pregenual cingulum. They also found that all active electrodes were located in the subgenual area [42].

As previously mentioned, some studies suggest the existence of a reduced fractional anisotropy in patients with bipolar disorder and depression [45,46,47,48]. McNab et al. [31] proposed that different pathological connectivity patterns could present a different response to treatment with DBS. In 2009, they reported a case of a patient with bipolar disorder who had suffered a stroke in the dorsomedial thalamic nucleus and since then had resistant depression. He underwent DBS of the subgenual region, which was not effective for the relief of his symptoms. The authors used probabilistic tractography to analyze the anatomical connections between the subgenual region and the rest of the brain, as well as connections between the amygdala and the stroke area, and its contralateral counterpart. They placed VOIs in these areas, and in each of the subgenual contacts in the area, and found that there were no pathways between the amygdala and the stroke, whereas some were found between the contralateral homologous regions. Connections were observed between the subgenual region and the amygdala, extending beyond the temporal lobe. However, the pathways of the amygdala to the subgenual region seemed reduced in the right hemisphere compared to the left. The patient died at 16 months after surgery, and a postmortem study with 3-tesla MRI was performed at a much higher resolution, with similar results. The authors concluded that the apparent reduction of structural connectivity of the ACC posterior subgenual region to the amygdala in the right side could have prevented the effectiveness of the treatment of the depressive symptoms by DBS [31].

The periventricular/periaqueductal gray (PVG/PAG) area has a key role in the modulation of nociceptive stimuli, since it is a basic structure of the central pain-inhibitory system [49]. It was one of the first areas in which DBS was successfully applied as a treatment for chronic pain [49]. However, there are still some outstanding issues related to the optimal stimulation site for different types of pain. Also, some studies have suggested that the PVG/PAG area might have a somatotopic organization, which is amenable to being studied with tractography [3,50].

Owen et al. [3,50] conducted two consecutive studies in order to identify the pathways involved in the DBS of the PVG/PAG for chronic pain. In 2007 [3], the authors studied a single patient, and in 2008 [50], 4 other patients undergoing DBS in the PAG/PVG area, with a good response. The chosen target was 2-3 mm lateral to the wall of the third ventricle, 2 mm above the level of the posterior commissure and at the level of the superior colliculus. Probabilistic tractography was performed, and areas of interest covering the 4 contacts were located on postoperative MRI. In the first case, they found connections from the active contact (contact 0) to many areas related to pain circuits, such as the orbitofrontal cortex, amygdala, anterior temporal gyrus, putamen, dorsomedial thalamus, reticular nucleus and anterior nucleus of the thalamus [3]. In particular, contacts 0 and 1 showed connections to the structures involved in processing the affective dimension of pain, such as the amygdala, orbitofrontal cortex and midanterior ventral posterolateral thalamic nucleus.

In the second study [50], connections were found in 3 of the 4 patients to the dorsomedial thalamus, precentral gyrus and central sulcus. Other areas observed in half of the patients were the superior frontal gyrus, superior temporal gyrus, anterior nucleus of the thalamus, putamen, internal capsule and superior colliculus as well as the centromedian thalamic and ventral posterolateral nucleus, caudate nucleus and cerebellum.

The authors concluded that the response of the patients was probably due to a modulation of the affective components of pain, rather than only of the sensory circuits. While some of the patients showed more connections to the sensory areas and the dorsomedial nucleus, other cases had balanced connections to both anterior and dorsomedial nuclei of the thalamus, which, according to the authors, could be related to different trajectories of the electrodes or to a somatotopy in the PVG/PAG [3,50].

Another group of researchers [51] used deterministic tractography for the planning of DBS of the spinothalamic tract, which, due to its low contrast, cannot be visualized with conventional MRI. They performed DTI in 4 patients with thalamic pain, at the level of the posterolateral internal capsule. Tractography helped to choose a target region in such a way that the DBS electrode covered, at a length of over 20 mm, the sensory fiber from the target in the direction of the entry point. At the 12-month follow-up, a pain relief of more than 40% by rating on a visual pain scale was achieved in 3 of the 4 patients [51].

Tractography may allow a better characterization of different pain syndromes, of the degree of involvement of the emotional components of pain in each patient and of the somatotopy of the PVG/PAG, which might help to optimize the selection of targets for chronic pain.

Tractography has being used in the field of DBS to help clarify relevant aspects in the selection of targets for stimulation. Studies are scarce so far, but they have provided data that, if confirmed, may be useful to optimize DBS surgery. White matter tracts such as the DRT and the MFB have been identified as potential targets for stimulation for tremor and depression, respectively [14,20,24,28,42,43,52,53]. The selection of optimal subregions within the usual targets, based on their connections with other brain areas, has advanced as well for the treatment of abnormal movements and pain [3,18,20,50]. If these results are confirmed, it is likely that tractography may be routinely used for the selection of targets in the near future.

The development of increasingly accurate research methods has advanced our knowledge about the brain structure and function. Thus, the current view of the brain is that of a group of cortical and subcortical interconnected structures forming a neural network which serves as the basis for the execution of brain functions. There is growing evidence that this network can be variable over time and modifiable by experiences of an individual [2].

Recent studies indicate that interruptions of integration or segregation within these network nodes may underlie the generation of certain neurological and psychiatric diseases, leading to changes in connectivity. In PD, for example, an increased connectivity between the cortex and the STN with respect to healthy subjects has been shown in functional MRI (fMRI) studies [54,55,56]. This increased connectivity seems to be related to the onset of phase coherence in the beta band (13-35 Hz) observed in these patients, which has been, in fact, correlated with the severity of tremor, bradykinesia and rigidity that they present [57]. Other studies have shown an increase in connectivity between the supplementary motor and primary motor areas and the cerebellum, as well as decreased connectivity between the putamen and cerebellum. In patients with dystonia, a decreased connectivity in the cerebellar projections to the ventral thalamus and from the globus pallidus to the cerebellum is characteristic [58]. In cervical dystonia, an asymmetry in connectivity has been found when comparing both sides [59]. Changes of connectivity have been observed in certain psychiatric conditions; for example, there seems to be a decrease in connectivity between the amygdala and the prefrontal cortex in patients with borderline personality disorder [33]. Studies suggest that schizophrenic patients have a significantly lower overall connectivity than healthy controls, while patients with bipolar disorder have an intermediate global connectivity which is significantly different than in schizophrenia patients and healthy controls [46,60]. In fact, the low global connectivity in all patients appears to be associated with worse clinical and neurophysiological functioning [6,33,60,61].

If a pathological synchronization of certain circuits appears to be a possible etiological mechanism for neurological and psychiatric diseases, the desynchronization of these circuits with the restoration of normal functional connectivity could be a therapeutic strategy and has been established as one of the fundamental mechanisms of action of DBS [2,57]. In fact, many of the subcortical structures that are stimulated by DBS as a treatment for neurological diseases show a generalized dense connectivity and may represent a constituent base node of the network [6,33]. According to this, techniques that determine the connectivity status of key brain areas, and that are able to assess whether the normal circuit connectivity after a treatment has been restored, might become fundamental tools for DBS surgery [2,22].

Studies comparing patients with neurological and psychiatric diseases and healthy volunteers using PET and fMRI have shown hyper- or hypoactivity in specific functional pathways and functional normalizations of these areas with pharmacological and nonpharmacological treatment options [62,63,64,65,66]. Although this approach might oversimplify the neurobiological interplay between structural and functional conditions, these findings have served as a rationale for the successful application of DBS in these areas for certain disorders [29,39]. The relationship between functional connectivity (studied by fMRI and PET) and structural connectivity (as shown by tract-tracing studies and DTI) has not yet been elucidated. Structural connections between brain regions are readily identified in nonhuman primates by using tract-tracing methods and DTI, as tracing studies in humans are not feasible because the most effective tracers require antemortem injections [67,68]. It has been suggested that functional connectivity reflects structural connectivity to a large degree; however, it appears that functional connectivity between regions with known or presumed structural connections varies depending on several contextual variables [67,68]. Whether DTI is able to reflect functional connectivity changes induced by DBS needs to be confirmed.

Tractography has emerged as a noninvasive technique capable of informing about the state of brain connectivity and the 3D location of white matter tracts in the brain. It has been used in the field of DBS to help clarify relevant aspects in the selection of targets and in evaluating the therapeutic effects of the stimulation. Studies are scarce so far, but they have provided data that, if confirmed, may be useful to optimize DBS surgery. It is possible that tractography may be routinely used in the selection of targets and the evaluation of results of DBS in the near future.

1.
McIntyre CC, Foutz TJ: Computational modeling of deep brain stimulation. Handb Clin Neurol 2013;116:55-61.
2.
Henderson JM: ‘Connectomic surgery': diffusion tensor imaging (DTI) tractography as a targeting modality for surgical modulation of neural networks. Front Integr Neurosci 2012;6:15.
3.
Owen SL, Heath J, Kringelbach ML, Stein JF, Aziz TZ: Preoperative DTI and probabilistic tractography in an amputee with deep brain stimulation for lower limb stump pain. Br J Neurosurg 2007;21:485-490.
4.
Kori P, Garg RK, Malhotra HS, Gupta RK, Verma R, Singh MK, et al: Evaluation of cerebral white-matter micro-structural alterations in patients with medically refractory epilepsy using diffusion tensor tractography. Epilepsy Res 2013;107:82-90.
5.
Butson CR, Cooper SE, Henderson JM, McIntyre CC: Patient-specific analysis of the volume of tissue activated during deep brain stimulation. Neuroimage 2007;34:661-670.
6.
Sedrak M, Gorgulho A, De Salles AF, Frew A, Behnke E, Ishida W, et al: The role of modern imaging modalities on deep brain stimulation targeting for mental illness. Acta Neurochir Suppl 2008;101:3-7.
7.
Sudhyadhom A, McGregor K, Okun MS, Foote KD, Trinastic J, Crosson B, et al: Delineation of motor and somatosensory thalamic subregions utilizing probabilistic diffusion tractography and electrophysiology. J Magn Reson Imaging 2012;37:600-609.
8.
Behrens TE, Johansen-Berg H, Woolrich MW, Smith SM, Wheeler-Kingshott CA, Boulby PA, et al: Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat Neurosci 2003;6:750-757.
9.
Traynor C, Heckemann RA, Hammers A, O'Muircheartaigh J, Crum WR, Barker GJ, et al: Reproducibility of thalamic segmentation based on probabilistic tractography. Neuroimage 2010;52:69-85.
10.
Hedera P, Phibbs FT, Dolhun R, Charles PD, Konrad PE, Neimat JS, et al: Surgical targets for dystonic tremor: considerations between the globus pallidus and ventral intermediate thalamic nucleus. Parkinsonism Relat Disord 2013;19:684-686.
11.
Torres CV, Pastor J, Navarrete EG, Sola RG: Deep brain stimulation for refractory epilepsy: extrathalamic targets (in Spanish). Rev Neurol 2011;53:153-164.
12.
Torres CV, Pastor J, Navarrete EG, Sola RG: Thalamic deep brain stimulation for refractory epilepsy (in Spanish). Rev Neurol 2011;53:99-106.
13.
Valentin A, Garcia Navarrete E, Chelvarajah R, Torres C, Navas M, Vico L, et al: Deep brain stimulation of the centromedian thalamic nucleus for the treatment of generalized and frontal epilepsies. Epilepsia 2013;54:1823-1833.
14.
Kalia SK, Sankar T, Lozano AM: Deep brain stimulation for Parkinson's disease and other movement disorders. Curr Opin Neurol 2013;26:374-380.
15.
Rodriguez-Oroz MC, Moro E, Krack P: Long-term outcomes of surgical therapies for Parkinson's disease. Mov Disord 2012;27:1718-1728.
16.
Yamamoto T, Katayama Y, Kano T, Kobayashi K, Oshima H, Fukaya C: Deep brain stimulation for the treatment of parkinsonian, essential, and poststroke tremor: a suitable stimulation method and changes in effective stimulation intensity. J Neurosurg 2004;101:201-209.
17.
Barkhoudarian G, Klochkov T, Sedrak M, Frew A, Gorgulho A, Behnke E, et al: A role of diffusion tensor imaging in movement disorder surgery. Acta Neurochir (Wien) 2010;152:2089-2095.
18.
Coenen VA, Allert N, Madler B: A role of diffusion tensor imaging fiber tracking in deep brain stimulation surgery: DBS of the dentato-rubro-thalamic tract (DRT) for the treatment of therapy-refractory tremor. Acta Neurochir (Wien) 2011;153:1579-1585, discussion 1585.
19.
Moreau C, Defebvre L, Devos D, Marchetti F, Destee A, Stefani A, et al: STN versus PPN-DBS for alleviating freezing of gait: toward a frequency modulation approach? Mov Disord 2009;24:2164-2166.
20.
Aravamuthan BR, Muthusamy KA, Stein JF, Aziz TZ, Johansen-Berg H: Topography of cortical and subcortical connections of the human pedunculopontine and subthalamic nuclei. Neuroimage 2007;37:694-705.
21.
Schweder PM, Joint C, Hansen PC, Green AL, Quaghebeur G, Aziz TZ: Chronic pedunculopontine nucleus stimulation restores functional connectivity. Neuroreport 2010;21:1065-1068.
22.
Hauptmann C, Tass PA: Restoration of segregated, physiological neuronal connectivity by desynchronizing stimulation. J Neural Eng 2010;7:056008.
23.
Torres CV, Moro E, Lopez-Rios AL, Hodaie M, Chen R, Laxton AW, et al: Deep brain stimulation of the ventral intermediate nucleus of the thalamus for tremor in patients with multiple sclerosis. Neurosurgery 2010;67:646-651, discussion 651.
24.
Klein JC, Barbe MT, Seifried C, Baudrexel S, Runge M, Maarouf M, et al: The tremor network targeted by successful VIM deep brain stimulation in humans. Neurology 2012;78:787-795.
25.
Pouratian N, Zheng Z, Bari AA, Behnke E, Elias WJ, Desalles AA: Multi-institutional evaluation of deep brain stimulation targeting using probabilistic connectivity-based thalamic segmentation. J Neurosurg 2011;115:995-1004.
26.
Xie T, Bernard J, Warnke P: Post subthalamic area deep brain stimulation for tremors: a mini-review. Transl Neurodegener 2012;1:20.
27.
Hassler R: Basal ganglia. Historical perspective. Appl Neurophysiol 1979;42:5-8.
28.
Coenen VA, Panksepp J, Hurwitz TA, Urbach H, Madler B: Human medial forebrain bundle (MFB) and anterior thalamic radiation (ATR): imaging of two major subcortical pathways and the dynamic balance of opposite affects in understanding depression. J Neuropsychiatry Clin Neurosci 2012;24:223-236.
29.
Lozano AM, Mayberg HS, Giacobbe P, Hamani C, Craddock RC, Kennedy SH: Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry 2008;64:461-467.
30.
Lujan JL, Chaturvedi A, Malone DA, Rezai AR, Machado AG, McIntyre CC: Axonal pathways linked to therapeutic and nontherapeutic outcomes during psychiatric deep brain stimulation. Hum Brain Mapp 2012;33:958-968.
31.
McNab JA, Voets NL, Jenkinson N, Squier W, Miller KL, Goodwin GM, et al: Reduced limbic connections may contraindicate subgenual cingulate deep brain stimulation for intractable depression. J Neurosurg 2009;111:780-784.
32.
McNeely HE, Mayberg HS, Lozano AM, Kennedy SH: Neuropsychological impact of Cg25 deep brain stimulation for treatment-resistant depression: preliminary results over 12 months. J Nerv Ment Dis 2008;196:405-410.
33.
New AS, Hazlett EA, Buchsbaum MS, Goodman M, Mitelman SA, Newmark R, et al: Amygdala-prefrontal disconnection in borderline personality disorder. Neuropsychopharmacology 2007;32:1629-1640.
34.
Torres CV, Sola RG, Pastor J, Pedrosa M, Navas M, Garcia-Navarrete E, et al: Long-term results of posteromedial hypothalamic deep brain stimulation for patients with resistant aggressiveness. J Neurosurg 2013;119:277-287.
35.
Torres CV, Ezquiaga E, Navas M, de Sola RG: Deep brain stimulation of the subcallosal cingulate for medication-resistant type I bipolar depression: case report. Bipolar Disord 2013;15:719-721.
36.
Lipsman N, Woodside B, Lozano AM: Evaluating the potential of deep brain stimulation for treatment-resistant anorexia nervosa. Handb Clin Neurol 2013;116:271-276.
37.
Lipsman N, Woodside DB, Giacobbe P, Hamani C, Carter JC, Norwood SJ, et al: Subcallosal cingulate deep brain stimulation for treatment-refractory anorexia nervosa: a phase 1 pilot trial. Lancet 2013;381:1361-1370.
38.
Lipsman N, Gerretsen P, Torres C, Lozano AM, Giacobbe P: A psychiatric primer for the functional neurosurgeon. J Neurosurg Sci 2012;56:209-220.
39.
Lozano AM, Giacobbe P, Hamani C, Rizvi SJ, Kennedy SH, Kolivakis TT, et al: A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression. J Neurosurg 2013;116:315-322.
40.
Lipsman N, McIntyre RS, Giacobbe P, Torres C, Kennedy SH, Lozano AM: Neurosurgical treatment of bipolar depression: defining treatment resistance and identifying surgical targets. Bipolar Disord 2010;12:691-701.
41.
Lozano AM, Hamani C: The future of deep brain stimulation. J Clin Neurophysiol 2004;21:68-69.
42.
Johansen-Berg H, Gutman DA, Behrens TE, Matthews PM, Rushworth MF, Katz E, et al: Anatomical connectivity of the subgenual cingulate region targeted with deep brain stimulation for treatment-resistant depression. Cereb Cortex 2008;18:1374-1383.
43.
Gutman DA, Holtzheimer PE, Behrens TE, Johansen-Berg H, Mayberg HS: A tractography analysis of two deep brain stimulation white matter targets for depression. Biol Psychiatry 2009;65:276-282.
44.
Hariz M, Blomstedt P, Zrinzo L: Future of brain stimulation: new targets, new indications, new technology. Mov Disord 2013;28:1784-1792.
45.
Sprooten E, Brumbaugh MS, Knowles EE, McKay DR, Lewis J, Barrett J, et al: Reduced white matter integrity in sibling pairs discordant for bipolar disorder. Am J Psychiatry 2013;170:1317-1325.
46.
Emsell L, Chaddock C, Forde N, Van Hecke W, Barker GJ, Leemans A, et al: White matter microstructural abnormalities in families multiply affected with bipolar I disorder: a diffusion tensor tractography study. Psychol Med 2014;44:2139-2150.
47.
Li J, Kale Edmiston E, Chen K, Tang Y, Ouyang X, Jiang Y, et al: A comparative diffusion tensor imaging study of corpus callosum subregion integrity in bipolar disorder and schizophrenia. Psychiatry Res 2014;221:58-62.
48.
Sarrazin S, Poupon C, Linke J, Wessa M, Phillips M, Delavest M, et al: A multicenter tractography study of deep white matter tracts in bipolar i disorder: psychotic features and interhemispheric disconnectivity. JAMA Psychiatry 2014;71:388-396.
49.
Torres CV, Sola RG: Neurosurgical techniques for the neuromodulation of pain (in Spanish). Rev Neurol 2011;53:677-687.
50.
Owen SL, Heath J, Kringelbach M, Green AL, Pereira EA, Jenkinson N, et al: Pre-operative DTI and probabilistic tractography in four patients with deep brain stimulation for chronic pain. J Clin Neurosci 2008;15:801-805.
51.
Hunsche S, Sauner D, Runge MJ, Lenartz D, El Majdoub F, Treuer H, et al: Tractography-guided stimulation of somatosensory fibers for thalamic pain relief. Stereotact Funct Neurosurg 2013;91:328-334.
52.
Bhatia KD, Henderson L, Ramsey-Stewart G, May J. Diffusion tensor imaging to aid subgenual cingulum target selection for deep brain stimulation in depression. Stereotact Funct Neurosurg 2012;90:225-232.
53.
Johansen-Berg H, Behrens TE, Sillery E, Ciccarelli O, Thompson AJ, Smith SM, et al: Functional-anatomical validation and individual variation of diffusion tractography-based segmentation of the human thalamus. Cereb Cortex 2005;15:31-39.
54.
Husarova I, Mikl M, Lungu OV, Marecek R, Vanicek J, Bares M: Similar circuits but different connectivity patterns between the cerebellum, basal ganglia, and supplementary motor area in early Parkinson's disease patients and controls during predictive motor timing. J Neuroimaging 2013;23:452-462.
55.
Shine JM, Matar E, Ward PB, Frank MJ, Moustafa AA, Pearson M, et al: Freezing of gait in Parkinson's disease is associated with functional decoupling between the cognitive control network and the basal ganglia. Brain 2013;136:3671-3681.
56.
Caviness JN: Pathophysiology of Parkinson's disease behavior: a view from the network. Parkinsonism Relat Disord 2014;20(suppl 1):S39-S43.
57.
Pogosyan A, Yoshida F, Chen CC, Martinez-Torres I, Foltynie T, Limousin P, et al: Parkinsonian impairment correlates with spatially extensive subthalamic oscillatory synchronization. Neuroscience 2010;171:245-257.
58.
Poston KL, Eidelberg D: Functional brain networks and abnormal connectivity in the movement disorders. Neuroimage 2012;62:2261-2270.
59.
Blood AJ, Kuster JK, Woodman SC, Kirlic N, Makhlouf ML, Multhaupt-Buell TJ, et al: Evidence for altered basal ganglia-brainstem connections in cervical dystonia. PLoS One 2012;7:e31654.
60.
Argyelan M, Ikuta T, DeRosse P, Braga RJ, Burdick KE, John M, et al: Resting-state fMRI connectivity impairment in schizophrenia and bipolar disorder. Schizophr Bull 2014;40:100-110.
61.
Yue Y, Yuan Y, Hou Z, Jiang W, Bai F, Zhang Z: Abnormal functional connectivity of amygdala in late-onset depression was associated with cognitive deficits. PLoS One 2013;8:e75058.
62.
Lawrence NS, An SK, Mataix-Cols D, Ruths F, Speckens A, Phillips ML: Neural responses to facial expressions of disgust but not fear are modulated by washing symptoms in OCD. Biol Psychiatry 2007;61:1072-1080.
63.
Mataix-Cols D, Wooderson S, Lawrence N, Brammer MJ, Speckens A, Phillips ML: Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry 2004;61:564-576.
64.
Mayberg HS: Positron emission tomography imaging in depression: a neural systems perspective. Neuroimaging Clin N Am 2003;13:805-815.
65.
Seminowicz DA, Mayberg HS, McIntosh AR, Goldapple K, Kennedy S, Segal Z, et al: Limbic-frontal circuitry in major depression: a path modeling metanalysis. Neuroimage 2004;22:409-418.
66.
Dougherty DD, Weiss AP, Cosgrove GR, Alpert NM, Cassem EH, Nierenberg AA, et al: Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression. J Neurosurg 2003;99:1010-1017.
67.
Greicius MD, Supekar K, Menon V, Dougherty RF: Resting-state functional connectivity reflects structural connectivity in the default mode network. Cereb Cortex 2009;19:72-78.
68.
Sharp DJ, Beckmann CF, Greenwood R, Kinnunen KM, Bonnelle V, De Boissezon X, et al: Default mode network functional and structural connectivity after traumatic brain injury. Brain 2011;134:2233-2247.
69.
Butson CR, Cooper SE, Henderson JM, Mc Intyre CC: Predicting the effects of deep brain stimulation with diffusion tensor based electric field models. Med Image Comput Comput Assist Interv 2006;9:429-437.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.